Blood-Brain Barrier and Pharmacokinetics
The effects of cannabis begin long before they are felt, shaped by how cannabinoids cross the blood-brain barrier and move through the body.
While some people don’t really care how Cannabis works - as long as it does - others are quite interested in the pharmacological action of the drug. By studying certain scientific topics, such as the blood-brain barrier, pharmacokinetics, and pharmacodynamics, it becomes a little easier to understand how cannabis acts inside our bodies, as well as why we get high or why effects can vary significantly from one person to another.
What Is the Blood-Brain Barrier?
Cannabis science has revealed a complex interaction between cannabinoids, the brain, and the body’s metabolic systems. One of those interactions is the blood-brain barrier (BBB), which is a highly selective protective system that separates the bloodstream from the brain and central nervous system.
The BBB is not just a regular physical wall, but it consists of tightly connected endothelial cells lining blood vessels in the brain, supported by additional cells that help regulate what enters and exits brain tissue.
It serves an essential purpose: it protects the brain and central nervous system from toxins, pathogens, and potentially harmful substances. At the same time, it allows vital compounds such as oxygen, glucose, and certain nutrients to pass through and support normal brain and nerve function.
This protective barrier is one reason many medications struggle to reach the brain. Researchers developing treatments for neurological disorders often face the challenge of designing drugs that can successfully cross the BBB while remaining safe and effective.
How THC and Other Cannabinoids Cross the BBB
One reason cannabis produces noticeable psychoactive effects is that its primary intoxicating compound, delta-9-tetrahydrocannabinol (THC), can cross the blood-brain barrier fairly easy. THC is highly lipophilic, meaning it readily dissolves in fats rather than water. This property helps it pass through cellular membranes and enter brain tissue.
Once inside the brain, THC primarily interacts with CB1 receptors, which are abundant in regions involved in memory, mood, reward, coordination, and perception. These interactions contribute to the characteristic effects associated with cannabis intoxication.
Cannabidiol (CBD) can also cross the blood-brain barrier, although it interacts with the endocannabinoid system differently and does not produce the intoxicating effects associated with THC. Researchers continue to investigate how CBD influences neurological signaling, inflammation, and other biological processes.
After consumption, THC is metabolized by the liver into several compounds, including 11-hydroxy-THC (11-OH-THC). This metabolite remains psychoactive and may contribute significantly to the effects of edible cannabis products, where liver metabolism occurs before THC reaches systemic circulation. This helps explain why edibles often feel stronger, last longer, and produce a different subjective experience than inhaled cannabis.
Cannabis Pharmacokinetics: What Happens After Consumption?
Pharmacokinetics is the study of how the body absorbs, distributes, metabolizes, and eliminates a substance. In simple terms, it examines what the body does to a drug after it is consumed.
Scientists often describe this process using the acronym ADME:
- Absorption: How a substance enters the bloodstream.
- Distribution: How it spreads throughout tissues and organs.
- Metabolism: How the body chemically transforms the substance.
- Excretion: How the substance and its metabolites leave the body.
Some researchers also include an additional step known as Liberation, which refers to how a compound is released from its formulation before absorption begins.
Cannabis pharmacokinetics are particularly complex because cannabinoids are highly fat-soluble. Following absorption, THC and related compounds can accumulate temporarily in fatty tissues throughout the body. This does not mean a person remains intoxicated for weeks, but cannabinoid metabolites may be detectable long after the psychoactive effects have ended.
Individual factors such as body composition, genetics, frequency of use, age, liver enzyme activity, and method of consumption can all influence cannabinoid pharmacokinetics.
Understanding cannabis pharmacology can help explain why different products, doses, and consumption methods produce different experiences. Video Source:
Pharmacology & Toxicology University of Toronto, YouTube
Why Different Consumption Methods Feel Different
Modern pharmacokinetic research has helped explain why smoking, vaporizing, and consuming edibles can produce dramatically different experiences.
When cannabis is inhaled through smoking or vaporization, cannabinoids enter the bloodstream through the lungs and reach the brain within minutes. Effects typically appear quickly and peak relatively early.
Edible cannabis follows a different pathway. Cannabinoids must first pass through the digestive system and liver before entering circulation. During this process, a portion of THC is converted into 11-hydroxy-THC. Because this transformation occurs before the compound reaches systemic circulation, edible cannabis often produces a slower onset but a more prolonged experience than inhaled products.
This difference in absorption and metabolism explains why equal amounts of THC can produce substantially different experiences depending on how they are consumed.
Pharmacokinetic research has also improved medical cannabis dosing strategies by helping clinicians and patients better understand onset times, duration of action, and expected therapeutic effects across various formulations.
Pharmacodynamics: How Cannabinoids Affect the Body
While pharmacokinetics examines what the body does to a drug, pharmacodynamics studies what the drug does to the body.
In the case of cannabis, pharmacodynamics focuses on how cannabinoids interact with biological targets such as cannabinoid receptors, neurotransmitter systems, enzymes, and signaling pathways. These interactions influence a wide range of effects, including mood, appetite, pain perception, memory, sleep, and motor function.
Research into cannabis pharmacodynamics has expanded considerably over the past decade. Scientists now recognize that cannabinoids produce their effects through a network of interactions that extends beyond CB1 and CB2 receptors alone. This complexity helps explain why cannabis can affect individuals differently and why certain cannabinoids may have distinct therapeutic profiles.
At the same time, researchers continue to investigate both the potential benefits and risks associated with cannabis use. Evidence supports therapeutic applications in areas such as chronic pain, chemotherapy-induced nausea, or seizure disorders, while certain questions remain regarding long-term effects, cognitive outcomes, and optimal medical use.
Conclusion
The relationship between cannabis and the human body is far more complex than simply getting “high.” The ability of cannabinoids to cross the blood-brain barrier, engage with the endocannabinoid system, and undergo extensive metabolism helps explain the wide range of effects associated with cannabis use.
As research continues to evolve, pharmacokinetics and pharmacodynamics remain two of the most important scientific tools for understanding how cannabinoids work, why different products produce different experiences, and how cannabis-based therapies may be used more effectively in the future.
Read more from Soft Secrets:
S
Soft Secrets
